EASL’s International Liver Congress™ in London was a great success. More than 7,000 delegates from 114 countries came together in London and online to discuss the latest science in hepatology.

Our colleagues presented of a 2021 study demonstrating that CRISPR–Cas9 gene editing can be deployed directly into the body to treat ATTR Amyloidosis – presenting longer-term prospects of a cure for the condition.

Find out more here >

Latest news

Richmond Pharmacology appoints Sandra Johnson as Director of Commercial Project Management

September 19, 2022
We are delighted to announce that Sandra Johnson will join Richmond Pharmacology as its new Director for Commercial Project Management
Read more

How telemonitoring can revolutionise the way we treat patients – Tom York

November 17, 2022
Richmond Pharmacology always searches for the most innovative processes to improve clinical trials and the patients’ experiences and treatments.
Read more


JPW2022 (Japan Basic and Clinical Pharmacology Week 2022)

30 November – 3 December 2022
This event will be the 96th Annual Meeting of the Japanese Pharmacological Society and the 43rd Annual Meeting of the Japanese Society of Clinical Pharmacology. 
View event